A Study to Learn How Safe Elinzanetant is, How it Affects the Body, and How it Moves Into, Through and Out of the Body After Single and Multiple Doses in Japanese Healthy Female Adults

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 11, 2021

Primary Completion Date

March 13, 2022

Study Completion Date

March 13, 2022

Conditions

Vasomotor Symptoms as a Sex Hormone-dependent Disorder in Women and Men

Interventions

DRUG

Elinzanetant (BAY3427080)

Oral administration

DRUG

Placebo

Oral administration

Trial Locations (1)

SOUSEIKAI Fukuoka Mirai Hospital, Fukuoka